There are many gastrointestinal motility drugs on the market, and morpholine (domperidone), which is often advertised, is a well-known motility drug, but do you know the difference between them? The indications of domperidone are: 1, to relieve the symptoms of indigestion caused by delayed gastric emptying, gastrointestinal reflux, esophagitis such as: epigastric distention, bloating, epigastric pain, belching, intestinal flatulence, heartburn with or without reflux gastric contents in the mouth; 2, treatment of functional, organic, infectious, dietary, radiotherapy or chemotherapy-induced nausea, vomiting; 3, peptic ulcer Adjuvant treatment; 4, to promote postpartum lactation. Indications of Moxaburi: mainly used for functional dyspepsia with heartburn, belching, nausea, vomiting, early satiety, epigastric distension and other digestive symptoms; also used for gastroesophageal reflux disease, diabetic gastroparesis and partial gastrectomy gastric dysfunction. It seems that there is not much difference between the two, but pharmacologically speaking, mosapride is a gastrointestinal motility drug and domperidone is a gastric motility drug, so if you are functional dyspepsia without organic disease, we suggest you mosapride, and if you are feeling full and uncomfortable immediately after eating, we suggest you domperidone.